Ynamide Click chemistry in development of triazole VEGFR2 TK modulators

European Journal of Medicinal Chemistry
Margaréta VojtičkováAndrej Boháč

Abstract

Structure novelty, chemical stability and synthetic feasibility attracted us to design 1,2,3-triazole compounds as potential inhibitors of VEGFR2 tyrosine kinase. Novel triazoles T1-T7 were proposed by oxazole (AAZ from PDB: 1Y6A)/1,2,3-triazole isosteric replacement, molecular modelling and docking. In order to enable synthesis of T1-T7 we developed a methodology for preparation of ynamide 22. Compound 22 was used for all Click chemistry reactions leading to triazoles T1-T3 and T6-T7. Among the obtained products, T1, T3 and T7 specifically bind VEGFR2 TK and modulate its activity by concentration dependent manner. Moreover predicted binding poses of T1-T7 in VEGFR2 TK were similar to the one known for the oxazole inhibitor AAZ (PDB: 1Y6A). Unfortunately the VEGFR2 inhibition by triazoles e.g. T3 and T7 is lower than that determined for their oxazole bioisosters T3-ox and AAZ, resp. Different electronic properties of 1,2,3-triazole/oxazole heterocyclic rings were proposed to be the main reason for the diminished affinity of T1-T3, T6 and T7 to an oxazole AAZ inhibitor binding site in VEGFR2 TK (PDB: 1Y6A or 1Y6B). Moreover T1-T3 and T6 were screened on cytotoxic activity against two human hepatocellular carcinoma cell lines. Se...Continue Reading

References

Apr 17, 1997·Nature·W Risau
Jan 20, 2000·Journal of Medicinal Chemistry·L F HennequinC Lambert-van der Brempt
Nov 15, 2000·The Journal of Organic Chemistry·J D Rainier, J E Imbriglio
May 31, 2002·Journal of Medicinal Chemistry·Daniel F VeberKenneth D Kopple
Jun 20, 2002·Journal of the American Chemical Society·Artis KlaparsStephen L Buchwald
Jan 10, 2003·Nucleic Acids Research·Tamotsu Noguchi, Yutaka Akiyama
Apr 3, 2003·Journal of the American Chemical Society·Claire M Coleman, Donal F O'Shea
Mar 6, 2004·Journal of Molecular Biology·Claudio N Cavasotto, Ruben A Abagyan
May 12, 2004·Nature Reviews. Drug Discovery·Napoleone FerraraWilliam Novotny
Sep 25, 2004·The Journal of Organic Chemistry·Florence MonginFrancis Marsais
Mar 4, 2005·Journal of Medicinal Chemistry·Philip A HarrisJeffrey A Stafford
Mar 18, 2005·Nature Reviews. Drug Discovery·Stuart L FinePeter Kirkpatrick
Mar 25, 2005·The Journal of Organic Chemistry·Ioannis SapountzisPaul Knochel
Nov 17, 2005·Journal of the American Chemical Society·Li ZhangGuochen Jia
Nov 23, 2005·Oncology·Peter Carmeliet
Mar 10, 2006·Organic Letters·Lopa V DesaiMelanie S Sanford
Apr 25, 2006·Nature Reviews. Molecular Cell Biology·Anna-Karin OlssonLena Claesson-Welsh
Sep 14, 2006·Angewandte Chemie·Chengfeng YeJean'ne M Shreeve
Oct 13, 2006·Molecular Diversity·Herman J Verheij
Feb 1, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Obdulia RabalJordi Teixidó
Apr 5, 2007·Nature Protocols·Vanicha Vichai, Kanyawim Kirtikara
Dec 15, 2007·Nature Protocols·Ryan A Altman, Stephen L Buchwald
Nov 11, 2008·The Journal of Organic Chemistry·Karin DooleweerdtTroels Skrydstrup
Feb 4, 2009·Bioorganic & Medicinal Chemistry Letters·Alexander S KiselyovVictor V Semenov
Feb 7, 2009·Organic Letters·Matthew D MorrisonDerek A Pratt
May 29, 2009·Angewandte Chemie·C Remzi BecerUlrich S Schubert
Sep 2, 2009·Journal of Medicinal Chemistry·John J IrwinYiqun Cao
Nov 19, 2009·Dalton Transactions : an International Journal of Inorganic Chemistry·Robert TrokowskiTatsuya Nabeshima
May 1, 2010·Chemical Reviews·Kyle A DeKorverRichard P Hsung
Jul 16, 2010·Investigational New Drugs·Francesca BuontempoMaria Luca Neri
Feb 9, 2012·Chemical Communications : Chem Comm·Guoxian GuPeng George Wang
May 2, 2012·The AAPS Journal·Stacey D Finley, Aleksander S Popel
Apr 1, 2010·Expert Opinion on Drug Discovery·Christian Beier, Martin Zacharias
Oct 3, 2012·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Maho Shibata, Michael M Shen
Feb 13, 2013·Beilstein Journal of Organic Chemistry·Miroslav MurárAndrej Boháč

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.